ALEX LAZAR: Open Payments
NPI 1154377315 · ENCINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,719 in 109 payments from 17 companies in 2025. Trend: 2023 $1,721 · 2024 $2,607 · 2025 $2,719
Food & beverage: $2,719
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $646 |
| Vanda Pharmaceuticals Inc. | 11 | $279 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $266 |
| Lundbeck LLC | 9 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $226 |
| Otsuka America Pharmaceutical, Inc. | 8 | $181 |
| Collegium Pharmaceutical, Inc. | 7 | $151 |
| Janssen Pharmaceuticals, Inc | 5 | $142 |
| Alkermes, Inc. | 6 | $139 |
| E.R. Squibb & Sons, L.L.C. | 4 | $104 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, TRINTELLIX, Jornay PM, SPRAVATO, COBENFY.
Industry payments across CA — which companies pay providers there.
